Case Studies in Melanoma

Mollie Reed, MSN, RN, ACNP-BC
Tennessee Oncology

Posted: 12/1/2017
Expires: 11/30/2018
Estimated time to complete: 30 minutes

Instructions for Earning CE credit

If you would like to earn credit, you must take the pre-test first by clicking here

Review CE information and Begin Pre-test

Case Studies in Melanoma

rowCount++; var rowCount = 0;

Case Studies in Melanoma

rowCount++;

Case Studies in Non-Small Cell Lung Cancer

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA
Winship Cancer Institute at Emory University

Posted: 12/1/2017
Expires: 5/31/2018
Credits/Contact Hours: 0.5

Case Studies in Non-Small Cell Lung Cancer

Quick Tips

Is programmed cell death ligand 1 (PD-L1) testing necessary?

When should you image patients to assess response to immunotherapy?

Why is pseudo-progression an important issue in patients on immune checkpoint inhibitors?

What are the mechanisms of action and adverse effects of these agents?

How do responses to immune checkpoint inhibitors differ from responses to chemotherapy?

What cancers are most likely to respond to immunotherapy?

How do you educate patients about the timing of early and latent side effects?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.